|Articles|March 21, 2005
Pharmaceutical Technology Europe
- Pharmaceutical Technology Europe-03-01-2005
- Volume 17
- Issue 3
European Biotech Second to US
Author(s)Gurminder Marwaha
The air of optimism surrounding the European biopharmaceutical industry seems to have dissipated...
Advertisement
Articles in this issue
almost 21 years ago
Taming the Regulatory Beast: Regulation versus Functionalismalmost 21 years ago
Field-Flow Fractionation With Multiangle Light Scatteringalmost 21 years ago
The Application of Cryogenics for Sustainable Solvent Recoveryalmost 21 years ago
Big Pharma Smells Parallel Trade Victoryalmost 21 years ago
Keeping Supply Chains Healthyalmost 21 years ago
Current Trends in Biomanufacturingalmost 21 years ago
The European Search for ResearchNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Industry Outlook 2026: Trends Transitioning from 2025 into 2026
2
Amgen Acquires UK Biotech Dark Blue Therapeutics
3
Navigating Financial and Opportunity Risks in Accelerated Drug Launches
4
Behind the Headlines Episode 31: Optimism, Opportunity, Optimization of COGs & Organizational Streamlining
5
